Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.20 USD
Change Today +0.16 / 2.27%
Volume 149.9K
CYTK On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert I. Blum

Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern,Cytokinetics, Incorporated
AgeTotal Calculated CompensationThis person is connected to 28 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Robert I. Blum has been President and Chief Executive Officer of Cytokinetics, Incorporated since January 2007. Mr. Blum previously served as President from February 2006 to January 2007, Executive Vice President, Corporate Development and Commercial Operations and Chief Business Officer from September 2004 to February 2006, Executive Vice President, Corporate Development and Finance and Chief Financial Officer from January 2004 to September 2004, Senior Vice President, ...

Read Full Background

Corporate Headquarters*

280 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-624-3000
Fax: 650-624-3010

Board Members Memberships*

Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern


Stanford University
Harvard Business School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$555,000

Stock Options*

Exercisable Options421,421
Exercisable Options Value$205,426
Unexercisable Options260,240
Unexercisable Options Value$190,822
Total Value of Options$396,247
Total Number of Options681,661

Total Compensation*

Total Annual Cash Compensation$878,010
Total Short Term Compensation$555,000
Total Calculated Compensation$2,188,910
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTK:US $7.20 USD +0.16


Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Andrew Philip Witty Chief Executive Officer, Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline S.A.E
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTOKINETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at